Rakuten Medical

Rakuten Medical

Private
San Mateo, CaliforniaHealthcare & Life Scienceshttps://www.rakuten-med.com

Last Round

Series F

1/7/2026

Total Funding Raised

$836.8M

Company Overview

Rakuten Medical is a biotechnology company that develops precision-targeted cancer therapies aimed at treating solid tumors through the use of monoclonal antibody conjugates activated by light to selectively eliminate cancer cells while preserving healthy tissue.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

photoimmunotherapyAlluminox platformdrug-device combinationhead and neck cancertargeted cancer therapyprecision oncologyantibody-drug conjugatelight-activated therapyHNSCCsolid tumor treatmentAkaluxBioBlade Laser Systemoncology platformcontract manufacturing organizationCMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rakuten Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rakuten Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series F1/7/2026
Series E3/6/2024
Series D7/28/2021
Series C Extension7/31/2019
Series C11/7/2018
Series B Extension
7/19/2017

Key People

Founding team and executive leadership

Hiroyuki Kodama

Chief Product Officer, Representative Director, President, Rakuten Medical K.K.

Executive Team

Andrew Liu

Chief Financial Officer

Executive Team

Rakuten Medical Investors

Notable investors and investment history

InvestorRounds
Daiwa Securities GroupSeries F
Sumitomo Mitsui Financial GroupSeries F
MS&AD Insurance Group HoldingsSeries F
NEXUS CVC Partners CorporationSeries F
General CatalystSeries D
ABIES CapitalSeries F
Mitsui Sumitomo InsuranceSeries F

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    New preclinical findings presented at AACR 2026 on photoimmunotherapy platform.

  • Apr 21, 2026

    Presented new preclinical findings at the AACR 2026 conference.

Rakuten Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rakuten Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rakuten Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Mateo, California
Employee Range129
Year Founded2013
Last Funding1/7/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.